The neurofibromatosis type 2 NF2 gene product, merlin, is a tumor suppressor frequently inactivated in malignant mesothelioma (MM). To investigate a possible correlation between merlin inactivation and MM invasiveness, we restored merlin expression in NF2-deficient MM cells. Re-expression of merlin markedly inhibited cell motility, spreading and invasiveness, properties connected with the malignant phenotype of MM cells. To test directly whether merlin inactivation promotes invasion in a nonmalignant system, we used small interfering RNA to silence Nf2 in mouse embryonic fibroblasts (MEFs) and found that downregulation of merlin resulted in enhanced cell spreading and invasion. To delineate signaling events connected with this phenotype, we investigated the effect of merlin expression on focal adhesion kinase (FAK), a key component of cellular pathways affecting migration and invasion. Expression of merlin attenuated FAK phosphorylation at the critical phosphorylation site Tyr397 and disrupted the interaction of FAK with its binding partners Src and p85, the regulatory subunit of phosphatidylinositol-3-kinase. In addition, NF2-null MM cells stably overexpressing FAK showed increased invasiveness, which decreased significantly when merlin expression was restored. Collectively, these findings suggest that merlin inactivation is a critical step in MM pathogenesis and is related, at least in part, with upregulation of FAK activity.
Introduction
Malignant mesotheliomas (MMs) are highly aggressive tumors characterized by pronounced invasiveness and rapid progression. Exposure to asbestos, a family of carcinogenic silicate fibers, is the main risk factor connected with the development of MM, although other factors may contribute to the development of this malignancy, such as hereditary factors and exposure to Simian virus 40 (Carbone et al., 2002) . Approximately 2500 new cases of MM are reported annually in the USA, and the rising worldwide incidence of the disease is not expected to peak for another 10 to 20 years. (Price, 1997; Price and Ware, 2004; Robinson and Lake, 2005) .
The neurofibromatosis type 2 (NF2) tumor suppressor gene is frequently inactivated in human MMs (Bianchi et al., 1995; Sekido et al., 1995; Cheng et al., 1999) . Germline mutations of this gene predispose individuals to NF2 disorder, which is characterized by benign intracranial and spinal tumors (Baser et al., 2003) . Merlin, the product of the NF2 gene, is structurally related to the Ezrin-Radixin-Moesin (ERM) family of proteins, which act as linkers between membrane proteins and the actin cytoskeleton to regulate cytoskeletal dynamics. Like the ERM proteins, merlin has an amino-terminal protein 4.1 family domain (FERM), followed by a long carboxyl-terminal alpha helical region. The localization of merlin at areas of membrane remodeling suggests a role in cell communication, adhesion and motility, functions related to the invasive properties of malignant cells. Other evidence in support of a possible role of merlin in tumor invasion comes from studies of Nf2-knockout animal models. Although Nf2-null mice die during embryonic development, mice heterozygous for a mutation at the Nf2 locus develop a range of highly invasive and metastatic tumors (McClatchey et al., 1998) . Moreover, Nf2 ( þ /À) mice are more susceptible to the MM development after exposure to asbestos than their wild-type counterparts (Fleury-Feith et al., 2003; Altomare et al., 2005) . In addition, the tumors that arise in these mice exhibit highly invasive properties, often with prominent vascularity and/or spreading to the surrounding tissues .
Focal adhesion kinase (FAK) is a cytoplasmic protein kinase that integrates signals from growth factor receptors and integrins to control cell adhesion, migration and invasion Mitra et al., 2005) . FAK expression and/or activity are reported to be upregulated in a wide range of malignancies, including cancers of the thyroid, prostate, cervix, colon, rectum, oral epithelium, ovary and breast (McLean et al., 2005; Watermann et al., 2005) . Ezrin, another member of the ERM family, has been shown to positively regulate FAK activity (Poullet et al., 2001) , and merlin itself has been proposed to form a complex with FAK and the Na þ /H þ exchanger regulatory factor, NHERF (James et al., 2004) .
Merlin has been previously reported to participate in pathways that control cell movement and proliferation in rat Schwannoma cells (Gutmann et al., 1999) . In this investigation, we tested the hypothesis that NF2 inactivation contributes to the enhanced migratory and invasive capacity of MM cells. We present evidence that NF2 inactivation promotes invasiveness and that merlin re-expression inhibits a wide range of cellular functions related to the malignant properties of MM cells. Moreover, we demonstrate that merlin negatively regulates FAK, a major component of pathways that control cell motility and invasiveness.
Results
Re-expression of active merlin suppresses MM cell invasion, spreading and motility Increased cell motility and invasiveness in vitro is thought to correlate with an enhanced malignant and invasive phenotype in vivo (Friedl and Wolf, 2003) . As MMs are highly aggressive and invasive tumors, we investigated the effects of re-expressing merlin in two MM cell lines (Meso17, Meso25) that lack expression of endogenous NF2. We and others have previously shown that phosphorylation of merlin on Serine 518 leads to relocalization and inactivation of the protein, whereas an unphosphorylatable mutant (NF2-518A) functions as a constitutively active protein (Rong et al., 2004; Surace et al., 2004; Xiao et al., 2005) . In cells, the availability of active, hypophosphorylated merlin is limited and tightly controlled (Lallemand et al., 2003) . In order to ensure the re-introduction of active merlin into a high percentage of MM cells, we used an adenovirus construct that expresses NF2-518A and green fluorescent protein (GFP). As shown in Figure 1a , GFP was expressed in more than 95% of the cells, confirming the expression of active merlin in virtually the entire cell population.
First, we compared the invasiveness of NF2-deficient MM cells infected with empty adenoviral vector (Advector) with that of cells infected with an adenovirus construct expressing active merlin (Ad-NF2-518A). Twelve hours post-infection, the cells were assayed for the ability to invade through a Matrigel membrane (invasion assay), as described in the Materials and methods. As shown in Figure 1b and c, re-expression of active merlin led to a marked decrease in cell invasion both in Meso17 and in Meso25 cells compared with the control-infected cells (approximately three and fivefold less invasion, respectively).
Tumor cell invasion is characterized by spreading of malignant cells into adjacent tissue. To determine whether re-introduction of active merlin affects the ability of MM cells to spread, we transfected Meso17 cells with constructs expressing hemagglutinin (HA)-tagged active merlin (518A), wild-type merlin and the N-and C-terminus of the protein by using nucleofection electroporation. Twenty-four hours after transfection, the cells were seeded onto fibronectin-coated coverslips and allowed to spread for 2 h. As shown in Figure 1d , after re-expression of active (518A) or wild-type merlin, the percentage of cells that spread was significantly decreased compared to the percentage of cells that spread after transfection with empty vector. Full-length merlin is necessary for the inhibitory effect on cell spreading, as overexpression of the merlin N-terminus showed only partial inhibition, whereas overexpression of the C-terminus of merlin did not have any effect on cell spreading.
We next tested the effect of merlin re-expression on the motility of MM cells by monitoring Meso17 cells using time-lapse videomicroscopy in a 'wound-healing' assay. A confluent monolayer of cells was scratched 6 h after infecting with Ad-vector or Ad-NF2-518A, and the cells were monitored as they moved to fill the wound. Re-introduction of merlin significantly inhibited the motility of the cells into the wound area. Cells expressing active merlin covered about half of the empty surface area that was covered by the control cells (36% and 67% of the initial vacant area, respectively) ( Figure  2a and b). We next estimated the 'velocity' of the cells by calculating the vacant area covered during different time points. As shown in Figure 2c , after an initial short period of relatively slow motility, both control and merlin-transfected cells started moving with accelerated velocity in order to fill the wound. As the gap was closing, the cells slowed down again as the opposite sides of the wound approached each other. Overall, cells reexpressing active merlin consistently moved with decreased velocity. The relative impairment in velocity of cells expressing merlin was apparent during the first 3 h after scratching the cell monolayer, and the degree of impairment relative to control cells remained about the same throughout the assay. Although re-population of the wound area involves both movement and cell division, the fact that expression of merlin results in reduced velocity even within the first few hours of the assay suggests a direct inhibitory effect on cell motility in addition to the known effect of merlin on cell cycle progression (Xiao et al., 2005) . Moreover, observation of the videos produced by time-lapse microscopy revealed that cells transfected with the empty vector appeared to move more quickly toward the center of the wound (data not shown).
Downregulation of endogenous merlin promotes invasion and spreading of mouse embryonic fibroblasts
Mouse embryonic fibroblasts (MEFs) are non-transformed, non-malignant cells in which merlin is expressed at physiological levels. In order to test directly if merlin inactivation promotes invasiveness, we used small interfering RNA (siRNA) to downregulate Nf2 in primary MEFs (passages 1-2). Transfection with an siRNA pool directed against Nf2 caused a marked decrease in the expression levels of the protein 48 and 72 h post-transfection, whereas a control siRNA pool had no effect on merlin expression (Figure 3a) . Having established the appropriate siRNA pool, we evaluated the effect of Nf2 downregulation on the invasiveness of MEF cells. Forty-eight hours post-transfection with control siRNA or siRNA against Nf2, cells were assayed for their ability to invade through Matrigel-coated filters towards 10% fetal bovine serum, used as a chemoattractant. As shown in Figure 3b and c, downregulation of Nf2 resulted in a threefold increase in the number of invading MEFs. We next tested the effect of merlin downregulation on cell spreading on fibronectin. Fortyeight hours post-transfection with siRNA, MEFs were trypsinized and replated on fibronectin-coated coverslips, and after 2 h the cells were fixed and stained for actin to score for cell spreading. As shown in Figure 3d , cells transfected with Nf2-siRNA spread significantly more than the control siRNA-transfected MEFs. These data show directly, in a non-malignant system, that Nf2 downregulation leads to increased cell invasiveness and spreading.
Re-expression of merlin attenuates FAK phosphorylation at Tyr397
Focal adhesion kinase, a ubiquitously expressed nonreceptor protein tyrosine kinase, has emerged as an important molecule that participates in pathways affecting cell motility and invasion McLean et al., 2005) . Ezrin, another member of the ERM family, is reported to participate in Src signaling and to induce FAK activation (Poullet et al., 2001; Srivastava et al., 2005) Although ezrin and merlin have similarities in structure and common interacting partners, such as CD44, NHERF and N-WASP (Bretscher et al., 2000; Morrison et al., 2001; Martin et al., 2003; Manchanda et al., 2005) , they possess opposite functions in cell growth and proliferation. As we observed an inhibitory effect of merlin on cell migration and invasion, we sought to determine if merlin could downregulate FAK. To address this question, we tested the effect of merlin overexpression on the total tyrosine phosphorylation status of FAK. Exponentially growing Meso17 cells were infected with Ad-NF2-518A or empty Ad-vector. Twenty-four hours after infection, cells were lysed, FAK was immunoprecipitated, and its tyrosine phosphorylation status was examined with a phospho-tyrosinespecific antibody. Expression of merlin led to decreased total tyrosine phosphorylation of FAK without affecting FAK expression levels. We also tested the levels of phosphorylation at Tyr397, the major site of FAK autophosphorylation (Schaller et al., 1994; Eide et al., 1995) , and found that expression of exogenous merlin attenuated FAK phosphorylation at Tyr397 (Figure 4 ).
Merlin inhibits invasiveness promoted by focal adhesion kinase overexpression
As increased FAK protein levels and activity are linked to increased cell invasion and migration (Owens et al., 1995; McLean et al., 2005) , we tested whether FAK overexpression in MM cells would lead to increased invasiveness. For this purpose, we created Meso17 cells that stably overexpress Flag-tagged FAK, and we used two clones (Meso17-FAK no. 17 and Meso17-FAK no. 18) for further analysis (Figure 5a) . A pool of Meso17 cells stably expressing empty vector was used as a control (Meso17-pcDNA3). Meso17-pcDNA3, Meso17-FAK no. 17 and Meso17-FAK no. 18 cells growing under selection conditions were infected with Ad-vector control or Ad-NF2-518A. Twelve hours post-infection, the cells were assayed for their ability to invade through Matrigel filters. Sixteen hours later, cells that had invaded through the filter were counted. Cells overexpressing FAK showed increased invasiveness compared with the control Meso-pcDNA3 cells (Figure 5b, empty bars) . However, expression of active merlin in cells overexpressing FAK resulted in markedly decreased cell invasiveness approximating that observed in Meso17-pcDNA3 cells (Figure 5b, filled bars) .
Merlin impairs the interaction of FAK with its binding partners Src and p85
Phosphorylation of FAK at Tyr397 creates a binding site for molecules containing SH2 domains, such as Src (Schaller et al., 1994) and the p85 subunit of phosphatidylinositol-3-kinase (PI3K) (Chen et al., 1996) . These interactions are essential for the activation of downstream signal-transduction cascades (Parsons, 2003; Mitra et al., 2005) . As merlin attenuates FAK phosphorylation at Tyr397, we further studied the consequences of this effect by testing the interaction of FAK with its binding partners Src and p85 after merlin overexpression. Meso17 cells stably expressing FAK-Flag were infected with Ad-vector or Ad-NF2-518A. Twenty-four hours after infection, the cells were lysed and equal amounts of antibodies were used to immunoprecipitate Src and p85. The amount of co-precipitated FAK was estimated by Western blot analysis using an antibody against the Flag epitope. As shown in Figure 5c , the amount of FAK coprecipitated with either Src or p85 after merlin overexpression was markedly reduced compared to that of the control cells.
Discussion
Malignant mesotheliomas are aggressive tumors that are primarily associated with exposure to asbestos fibers (Robinson and Lake, 2005) . The long latency between the initial exposure to asbestos and the development of MM, as well as the fact that only a small fraction of persons exposed to asbestos develop MM, suggest that certain somatic genetic alterations may be crucial for the development of the disease. Indeed, an accumulation of key molecular genetic changes are commonly found in MM, including inactivation of CDKN2A/ARF, encoding the tumor suppressors p16
INK4a and p14 ARF and NF2 (Bianchi et al., 1995; Sekido et al., 1995; Lee and Testa, 1999; Carbone et al., 2002) .
Malignant mesothelioma is a highly invasive type of cancer. Although metastases are rarely the cause of death, massive local spreading is common and may result in lymph node involvement as well as obstruction of the superior vena cava, cardiac tamponade, subcutaneous extensions and spinal cord compression (Robinson and Lake, 2005) . The NF2 product, merlin, is a well-established tumor suppressor with growth suppressive properties. However, several lines of evidence also implicate merlin inactivation in the increased invasive capacity of MM cells. Merlin is structurally related to ERM family members involved in the control of cytoskeletal changes and motility (Bretscher , 2002) , and modulation of cell shape by remodeling of the cytoskeleton is prerequisite for invasive growth (Wells, 2000) . Furthermore, overexpression of merlin has been shown to inhibit motility and spreading in rat Schwannoma cells (Gutmann et al., 1999) . Moreover, Nf2( þ /À) mice exhibit a wide range of highly invasive and metastatic tumors (McClatchey et al., 1998) . Finally, Nf2( þ /À) mice exposed to asbestos exhibit accelerated formation of highly malignant mesothelial tumors (Fleury-Feith et al., 2003; Altomare et al., 2005) . Our data suggest that NF2 inactivation plays an important role in cell invasiveness, as demonstrated by both 'loss-of-function' studies on primary MEFs and 'gain-of-function' experiments with NF2-deficient MM cells.
Merlin has been reported to interact with several proteins and has been implicated in a range of cellular and molecular functions (Gusella et al., 1999; McClatchey and Giovannini, 2005) . One of the key questions regarding merlin function is whether it performs multiple independent functions, one of which is critical for tumor suppression, or whether merlin regulates a specific combination of pathways that collectively impart tumor suppression. In any case, although there is evidence for a role of merlin in the cell nucleus (Muranen et al., 2005) , it seems that merlin localizes mainly in the membrane protrusions and lamellopodia and functions by participating in tertiary protein complexes in close proximity to the cell membrane.
In this work, we demonstrate a previously unreported role of merlin. We present evidence that merlin negatively regulates FAK, a major component of pathways that regulate cell motility and invasion. We show that merlin overexpression attenuates FAK tyrosine phosphorylation and, more specifically, leads to decreased phosphorylation at the major FAK autophosphorylation site, Tyr397. Phosphorylation at Tyr397 is a critical event for the subsequent binding of SH2-containing proteins, including the Src family kinases and the p85 subunit of PI3K. Binding of Src initiates signaling to downstream effectors of FAK by Src-mediated transphosphorylation of additional phosphorylation sites within the kinase domain activation loop to maximize the catalytic activity of FAK, whereas binding of p85 leads to PI3K activation (Mitra et al., 2005) . We investigated the consequences of the attenuation of FAK phosphorylation at Tyr397 by merlin on the ability of FAK to bind Src and p85. Our findings indicate that merlin overexpression leads to disruption of FAK binding to its interacting partners Src and p85. The inhibitory effect of merlin on FAK activity could be either direct, as merlin has been previously shown to form a complex with FAK and NHERF (James et al., 2004) , or indirect through inhibition of Rac/PAK signaling, which is known to cross-talk with FAK signaling (Hsia et al., 2003; Brown et al., 2005; Mitra et al., 2005) . Indeed, we and others have previously linked merlin to Rac/PAK signaling, as PAK was found to be able to phosphorylate and inactivate merlin (Kissil et al., 2002; Xiao et al., 2002) and unphosphorylated merlin has been shown to inhibit PAK activity (Kissil et al., 2003; Hirokawa et al., 2004; Xiao et al., 2005) and Rac translocation to matrix adhesions (Okada et al., 2005) . PAK activity has been shown to affect cell motility and directionality (Sells et al., 1999) . Furthermore, Rac participates in the regulation of actin dynamics and motility, and there is evidence connecting Rac upregulation to increased cell invasion (Mareel and Leroy, 2003) .
There is accumulating evidence supporting a role of FAK upregulation on the neoplastic transformation of different types of cells McLean et al., 2005) . Moreover, FAK expression has been shown to associate with tumor invasiveness (Owens et al., 1995; Gabarra-Niecko et al., 2003) , and increased FAK expression/activity is frequently correlated with highly malignant or metastatic tumors having a poor prognosis (McLean et al., 2005) . Our data indicate that stable overexpression of FAK in MM cells increases their invasiveness, and that re-expression of merlin can markedly suppress FAK-related invasiveness.
Collectively, our findings support a model in which NF2 inactivation is a critical step in the development of the invasive properties of MM cells and that this 'lossof-function' event is connected, at least in part, with the simultaneous upregulation of FAK activity.
Materials and methods
Cell lines, reagents and antibodies NF2-deficient human MM cell lines Meso17 and Meso25 were cultured in Roswell Park Memorial Institute media (RPMI)/ 10% fetal bovine serum (FBS) supplemented with antibiotics. Mouse embryonic fibroblasts were cultured in Dulbecco's modified Eagle's medium/10% FBS supplemented with 2 mM L-glutamine, 1.0 mM sodium pyruvate and antibiotics.
The antibodies used in this study were as follows: monoclonal anti-HA, HA.11 (Covance, Princeton, NJ, USA), polyclonal anti-NF2 (A-19), and monoclonal anti-c-Src (B-12) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), monoclonal anti-FAK (BD-Biosciences, Franklin Lakes, NJ, USA), anti-p85 (PI3K) and monoclonal anti-phosphotyrosine antibody (4G10) (Upstate, Lake Placid, NY, USA) and phospho-397 FAK (Biosource, Camarillo, CA, USA). Fibronectin, and monoclonal antibodies against Flag, alpha-tubulin and actin were from Sigma, (St Louis, MO, USA). The adenoviral construct Ad-GFP-HA-NF2-518A was described previously (Xiao et al., 2005) . cDNA expressing human wild-type NF2, NF2-518A, NF2 (1-299), NF2 (300-595) and Flag-tagged human FAK were cloned in pcDNA3.1 expression vector (Invitrogen, Carlsbad, CA, USA), and the constructs were fully sequenced.
Immunoprecipitation
Cultured cells were lysed in ice-cold lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na 2 -ethylenediaminetetraacitic acid, 1 mM ethyleneglycol tetraacetate, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na 3 VO 4 , 1 mg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride). Then 500-1000 mg of cell lysate were incubated for 2 h at 41C with 1-2 mg of the appropriate antibody, followed by incubation for 2 h with protein G-agarose (Invitrogen). After washing three times, the beads were resuspended in 40 ml of sample buffer. Samples were analysed by immunoblotting. For the FAK-Src and FAK-p85 co-immunoprecipotation experiments, cells were lysed in RIPA lysis buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 0.1% sodium dodecyl sulfate (SDS), 0.5% sodium dehoxycolate and protease inhibitors as reported previously (Salazar and Rozengurt, 1999) . Cell lysates were incubated overnight at 41C with the appropriate primary antibodies and subsequently for 2 h with protein G-agarose or protein A-agarose (both from Invitrogen). After washing three times, beads were resuspended in 40 ml of sample buffer and analysed by immunoblotting.
Nucleofection
Nucleofection was carried out using an Amaxa Nucleofector apparatus according to the manufacturer's recommendations, with nucleofection solution 'R' and program A-23 for Meso17 cells, and solution 'MEF2' and program T-20 for MEFs.
Stable transfections
Meso17 cells were transfected with pcDNA3-FAK-Flag or with pcDNA3 vector alone by nucleofection as described above. Stable transfectants were selected after 3-4 weeks of culture in medium containing G418 (500 mg/ml). Two clones expressing FAK-Flag were used (clone nos. 17 and 18). A pool of pcDNA3 vector-expressing cells was used as a control (Meso17-pcDNA3).
Wound-healing assay and time-lapse videomicroscopy For the wound-healing assay monitored by time-lapse videomicroscopy, cells were seeded into six-well plates and grown to confluency. Six hours after infection with adenoviral construct, a single wound was made down the center of each well using a sterile pipette tip. Phase-contrast time-lapse images were captured at 10-min intervals over a 24-h period using a Nikon TE2000 microscope equipped with a chamber with a forced-air heater, allowing for temperature control. The surface area covered by the cells was estimated with MetaVue software. The 'velocity' of the cells was estimated as the average area covered per hour over various time periods.
Cell spreading
Coverslips were coated with fibronectin (5 mg/ml) for 1 h at 371C, and subsequently with FBS for an additional hour at 371C. Cells were serum-starved, trypsinized, allowed to recuperate for 30 min in suspension at 371C and then plated on fibronectin-coated coverslips. After 2 h, the cells were fixed and F-actin was stained with TRITC-phalloidin (Molecular Probes-Invitrogen). For each experiment, cells were counted from three random fields using a Â 40 objective. Non-spread cells were defined as round, phase-bright cells; spread cells were defined as those that had extended processes, lacked a round morphology and were not phase-bright. The percentage of spread cells after transfection of vector alone was set to 100, and the percentages of cells that spread after transfection with the different plasmids were calculated and normalized accordingly.
Matrigel invasion assay
In vitro invasion was measured using 24-well BioCoat Matrigel invasion chambers (Becton Dickinson Labware, Franklin Lakes, NJ, USA). The lower compartment contained RPMI medium with 10 ng/ml hepatocyte growth factor (HGF) as a chemoattractant for MM cells or 10% FBS for MEFs. In the upper compartment, 2.5 Â 10 4 cells/well were placed in serumfree medium and incubated overnight at 371C in a humidified incubator with 5% CO 2 . The invading cells on the underside of the filter were fixed with 10% formaldehyde and stained with hematoxylin solution. Cells were observed and counted with a phase-contrast microscope, and invasion was estimated as the average number of cells in five fields using a Â 10 objective.
Small interfering RNA technology Small interfering RNA against Nf2 (SMARTpool) and control siRNA were purchased from (Dharmacon, Lafayette, CO, USA). Cells were transfected with an Amaxa Nucleofector with 100 nM siRNA for Nf2 or control siRNA. After 48 h posttransfection, the cells were trypsinized and subsequently subjected to invasion assay or plated onto fibronectin-coated coverslips for 2 h to estimate cell spreading.
Statistical analysis
All P-values between controls and subjects were calculated with the use of two-tailed t-test. Differences with P-values of less than 0.05 were considered significant.
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